VECT vs. ALVO, AMGN, GILD, MRNA, BIIB, BNTX, ARGX, NBIX, TECH, and QGEN
Should you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Alvotech (ALVO), Amgen (AMGN), Gilead Sciences (GILD), Moderna (MRNA), Biogen (BIIB), BioNTech (BNTX), argenx (ARGX), Neurocrine Biosciences (NBIX), Bio-Techne (TECH), and Qiagen (QGEN). These companies are all part of the "biological products, except diagnostic" industry.
VectivBio (NASDAQ:VECT) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking.
Alvotech has a consensus price target of $13.33, suggesting a potential downside of 3.94%. Given Alvotech's higher probable upside, analysts plainly believe Alvotech is more favorable than VectivBio.
In the previous week, Alvotech had 6 more articles in the media than VectivBio. MarketBeat recorded 7 mentions for Alvotech and 1 mentions for VectivBio. Alvotech's average media sentiment score of 0.26 beat VectivBio's score of 0.00 indicating that Alvotech is being referred to more favorably in the news media.
VectivBio has higher earnings, but lower revenue than Alvotech.
VectivBio has a net margin of 0.00% compared to Alvotech's net margin of -633.61%.
VectivBio received 5 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 43.48% of users gave VectivBio an outperform vote while only 41.67% of users gave Alvotech an outperform vote.
Summary
VectivBio and Alvotech tied by winning 5 of the 10 factors compared between the two stocks.
Get VectivBio News Delivered to You Automatically
Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VECT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VectivBio Competitors List
Related Companies and Tools
